BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Novartis India Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500672
ISIN Demat
INE234A01025
Book Value (Rs)
313.912669
NSE Symbol
NOVARTIND
Divident Yield %
2.25
Market Cap
(Rs In Cr.)
2,747
P/E (TTM)
28.25
EPS (TTM)
39.38
Face Value
(Rs)
5
Back
Novartis India standalone net profit rises 18.67% in the September 2025 quarter
28-Oct-25   Hrs IST

Net profit of Novartis India rose 18.67% to Rs 24.22 crore in the quarter ended September 2025 as against Rs 20.41 crore during the previous quarter ended September 2024. Sales rose 3.71% to Rs 90.33 crore in the quarter ended September 2025 as against Rs 87.10 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales90.3387.10 4
OPM %26.4420.62 -
PBDT33.1728.14 18
PBT32.6527.56 18
NP24.2220.41 19

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)